Principal Financial Group Inc Vir Biotechnology, Inc. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

A detailed history of Principal Financial Group Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 434,626 shares of VIR stock, worth $3.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

434,626

Previous 462,030 5.93%

Holding current value

$3.27 Million

Previous $4.68 Million 17.35%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$7.63 - $12.66 $209,092 - $346,934	-27,404 Reduced 5.93%	434,626 $3.87 Million
Q1 2024 Apr 29, 2024	SELL	$8.6 - $11.9 $392,134 - $542,604	-45,597 Reduced 8.98%	462,030 $4.68 Million
Q4 2023 Feb 07, 2024	SELL	$7.76 - $10.29 $31,544 - $41,828	-4,065 Reduced 0.79%	507,627 $5.11 Million
Q3 2023 Nov 02, 2023	BUY	$9.14 - $24.62 $363,424 - $978,940	39,762 Added 8.43%	511,692 $4.79 Million
Q2 2023 Aug 07, 2023	SELL	$23.2 - $27.29 $154,419 - $181,642	-6,656 Reduced 1.39%	471,930 $11.6 Million
Q1 2023 May 09, 2023	SELL	$22.26 - $30.85 $228,788 - $317,076	-10,278 Reduced 2.1%	478,586 $11.1 Million
Q4 2022 Feb 09, 2023	BUY	$19.96 - $28.22 $162,035 - $229,089	8,118 Added 1.69%	488,864 $12.4 Million
Q3 2022 Nov 09, 2022	BUY	$18.26 - $31.1 $160,888 - $274,022	8,811 Added 1.87%	480,746 $9.27 Million
Q2 2022 Aug 10, 2022	BUY	$19.08 - $26.7 $8.51 Million - $11.9 Million	445,904 Added 1712.97%	471,935 $12 Million
Q1 2022 May 09, 2022	BUY	$21.19 - $40.01 $3,242 - $6,121	153 Added 0.59%	26,031 $670,000
Q4 2021 Feb 09, 2022	SELL	$30.97 - $54.03 $389,045 - $678,724	-12,562 Reduced 32.68%	25,878 $1.08 Million
Q3 2021 Nov 09, 2021	SELL	$34.9 - $54.54 $39,018 - $60,975	-1,118 Reduced 2.83%	38,440 $1.67 Million
Q2 2021 Aug 10, 2021	SELL	$38.75 - $51.0 $20,925 - $27,540	-540 Reduced 1.35%	39,558 $1.87 Million
Q1 2021 May 10, 2021	BUY	$26.34 - $83.07 $7,559 - $23,841	287 Added 0.72%	40,098 $2.06 Million
Q4 2020 Feb 08, 2021	BUY	$25.51 - $43.38 $216,937 - $368,903	8,504 Added 27.16%	39,811 $1.07 Million
Q3 2020 Nov 06, 2020	SELL	$28.28 - $53.6 $2,432 - $4,609	-86 Reduced 0.27%	31,307 $1.07 Million
Q2 2020 Aug 05, 2020	BUY	$27.89 - $47.86 $875,550 - $1.5 Million	31,393 New	31,393 $1.29 Million

Others Institutions Holding VIR

# of Institutions

233

Shares Held

87.6M

Call Options Held

231K

Put Options Held

132K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $999M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Vir Biotechnology, Inc. Transaction History